Evidence map›Paper›PMID 19739070›Full record

ArticleInternational journal of cancer2010

Mismatch repair system decreases cell survival by stabilizing the tetraploid G1 arrest in response to SN-38.

Mandar Ramesh Bhonde, Marie-Luise Hanski, Jenny Stehr, Britta Jebautzke, Roser Peiró-Jordán, Henry Fechner, Kazunari Kazushige Yokoyama, Weei-Chin Lin, Martin Zeitz, Christoph Hanski

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer.International journal of environmental research and public health · 2016
    Review
  3. Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Mandar Ramesh BhondeDepartment of Gastroenterology, Charité, Campus Benjamin Franklin, Berlin, Germany.
Marie-Luise Hanski
Jenny Stehr
Britta Jebautzke
Roser Peiró-Jordán
Henry Fechner
Kazunari Kazushige Yokoyama
Weei-Chin Lin
Martin Zeitz
Christoph Hanski
Charité - Universitätsmedizin Berlin · DEFranklin University · USKaohsiung Medical University · TWUniversity of Alabama at Birmingham · US

Funding

The ATM/E2F1 Pathway in DNA Damage and Growth ControlR01CA100857 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LIN, WEEI-CHIN · 2004 to 2019
$4.8M
Therapeutic Targeting of Oncogenic Stress in Cancer TreatmentR01CA138641 · NCI · BAYLOR COLLEGE OF MEDICINE · PI LIN, WEEI-CHIN · 2010 to 2014
$1.5M
NCI NIH HHS R01 CA100857NCI NIH HHS R01 CA138641
6 · The paper itself

Abstract

The role of the mismatch repair (MMR) system in correcting base-base mismatches is well established; its involvement in the response to DNA double strand breaks, however, is less clear. We investigated the influence of the essential component of MMR, the hMLH1 protein, on the cellular response to DNA-double strand breaks induced by treatment with SN-38, the active metabolite of topoisomerase I inhibitor irinotecan, in a strictly isogenic cell system (p53(wt), hMLH1(+)/p53(wt), hMLH1(-)). By using hMLH1 expressing clones or cells transduced with the hMLH1-expressing adenovirus as well as siRNA technology, we show that in response to SN-38-induced DNA damage the MMR proficient (MMR(+)) cells make: (i) a stronger G2/M arrest, (ii) a subsequent longer tetraploid G1 arrest, (iii) a stronger activation of Chk1 and Chk2 kinases than the MMR deficient (MMR(-)) counterparts. Both Cdk2 and Cdk4 kinases contribute to the basal tetraploid G1 arrest in MMR(+) and MMR(-) cells. Although the Chk1 kinase is involved in the G2/M arrest, neither Chk1 nor Chk2 are involved in the enhancement of the tetraploid G1 arrest. The long-lasting tetraploid G1 arrest of MMR(+) cells is associated with their lower clonogenic survival after SN-38 treatment, the abrogation of the tetraploid G1 arrest resulted in their better clonogenic survival. These data show that the stabilization of the tetraploid G1 arrest in response to double strand breaks is a novel function of the MMR system that contributes to the lesser survival of MMR(+) cells.

Indexed as

Adaptor Proteins, Signal TransducingAntineoplastic Agents, PhytogenicApoptosisBlotting, WesternCamptothecinCell SurvivalCheckpoint Kinase 1Cyclin-Dependent Kinase 2Cyclin-Dependent Kinase 4DNA DamageDNA Mismatch RepairG1 PhaseHumansIrinotecanMutL Protein Homolog 1NeoplasmsAdaptor Proteins, Signal TransducingAntineoplastic Agents, PhytogenicCamptothecinCDK2 protein, humanCDK4 protein, humanCheckpoint Kinase 1CHEK1 protein, humanCyclin-Dependent Kinase 2Cyclin-Dependent Kinase 4IrinotecanMLH1 protein, humanMutL Protein Homolog 1Nuclear ProteinsProtein KinasesRNA, MessengerRNA, Small InterferingTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID19739070
PMCPMC4205106
OpenAlexW1980308039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.